U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Nestle Infant Nutrition - 07/13/2015
  1. Warning Letters


Nestle Infant Nutrition

Nestle Infant Nutrition

United States

Issuing Office:

United States


Department of Health and Human Services' logoDepartment of Health and Human Services

Public Health Service
 Food and Drug Administration
College Park, MD 20740


July 13, 2015

Mr. Gary Tickle
President and CEO
Nestle Infant Nutrition
12 Vreeland Rd, 2nd Floor
Florham Park, NJ 07932-0697

Dear Mr. Tickle:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter Case #441393 issued October 31, 2014. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency, expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.



Carrie J. Lawlor
Acting Branch Chief
Labeling and Dietary Supplement
         Compliance Branch
Division of Enforcement
Office of Compliance
Center for Food Safety
         and Applied Nutrition

Back to Top